T
CDLX icon

TCWP’s Cardlytics CDLX Stock Holding History

TCWP’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3
Closed -$1K – 528
2022
Q1 		$1K Buy
+3
New +$1.81K ﹤0.01% 1463

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TCWP's CDLX Position: Q2 2022 in Review

TCWP sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 3 shares — an estimated $1K sold.

TCWP first reported a position in CDLX in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • TCWP reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 3 Cardlytics shares in Q2 2022, an estimated $1K.
  • TCWP first reported a position in Cardlytics in Q1 2022 and held it in 1 quarter.
  • TCWP's Cardlytics position peaked at $1K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.